PDX Portal

Model Details

Patient Information for Model: TCH-AML003

Model Contact

Model: TCH-AML003
Model Contact: Michele Redell
Institution: TCH Leukemia PDX Program
Email: mlredell@texaschildrens.org

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations

Model Information for Model: TCH-AML003

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

There are no omics data for this model.

Histology Information for Model: TCH-AML003

There are no histology images for this model.

Metastasis Information for Model: TCH-AML003

Patient

PDX

Central Nervous System

Face

Gingiva

Liver

Lymph node

Orbital chloroma

Retinas

Skin

Spleen

Testis

Tongue

Patient Treatment Information for Model: TCH-AML003

Event Id	Treatment	Treatment Setting	Age at Start	Duration	Clinical Response	CNS Response	Measurable Residual Disease
10	Vyxeos	De Novo	7.14	1Unknown		CSF Positive	80%
20	FLAG	De Novo	7.25	1Unknown	Remission		0%
35	decitabine/vorinostat/FLAG	Relapse	7.38	1Unknown			4%
50	TVTC	Relapse	7.54	1Unknown			5%